Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

5.93
Delayed Data
As of 11:46am ET
 +0.05 / +0.85%
Today’s Change
4.38
Today|||52-Week Range
7.16
+3.67%
Year-to-Date
No recent news for Sinovac Biotech Ltd.

Today’s Trading

Previous close5.88
Today’s open5.91
Day’s range5.90 - 5.93
Volume27,030
Average volume (3 months)78,281
Market cap$334.6M
Dividend yield--
Data as of 11:46am ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)+600.00%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+6.84%
P/E ratioNM
Price/Sales4.78
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...+0.24+2.75%
CRVSCorvus Pharmaceutica...+0.20+1.23%
CLSDClearside Biomedical...+0.93+5.64%
KPTIKaryopharm Therapeut...+0.33+3.49%
Data as of 12:04pm ET, 09/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$0.05
Annual revenue (last year)$67.4M
Annual profit (last year)-$1.1M
Net profit margin-0.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Wei Dong Yin
Chief Financial Officer
Nan Wang
Corporate headquarters
Beijing, Beijing

Forecasts

Search for Jobs